Immusoft

Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells.

Immusoft is a Seattle-based biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP) technology were developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft.